Deadline 6th October
The Medicines and Healthcare products Regulatory Agencywant to adopt a more systematic approach to listening to and involving patients – ensuring that the patient voice is heard when safety issues, concerning medicines or medical devices, are identified and in the licensing of new medicines.
They also plan to do more to communicate about who they are and the results of their work.
They would like to hear from:
- patient group representatives
- healthcare professionals
By taking part you will help to identify what the priorities should be for patient engagement and involvement in the future.